Remedy Meds

About Remedy Meds

Remedy Meds is a telehealth weight-loss platform founded in 2022 that specializes in compounded semaglutide and tirzepatide prescriptions. The company has quickly scaled into one of the higher-volume GLP-1 providers in the direct-to-consumer space, processing thousands of patients through a streamlined digital onboarding flow. Pricing ranges from 9 to ,399 per month depending on medication type and dosage tier, placing Remedy Meds in the mid-to-upper price bracket among compounded-only providers.

One of Remedy Meds’ standout features is its outcome guarantee, a policy the company advertises prominently. While the specific terms and conditions of this guarantee vary, it signals a level of confidence in their treatment protocols that most competitors do not offer. The onboarding process is notably fast, with many patients reporting prescriptions issued within 24 to 48 hours of completing their intake questionnaire. For patients eager to start treatment without lengthy wait times, this is a genuine advantage.

On Trustpilot, Remedy Meds holds a 4.6-star rating across 11,450+ reviews, which is a strong score at significant volume. Positive reviews frequently cite fast shipping and responsive initial consultations. However, recurring complaints center on billing transparency, auto-renewal charges, and difficulty reaching support after the first prescription is filled. The volume of reviews gives this rating meaningful statistical weight.

The company holds an F rating with the Better Business Bureau, driven largely by unresolved consumer complaints related to refunds and subscription cancellations. This is a pattern we see across several high-volume telehealth providers, but it remains a red flag that prospective patients should weigh carefully. Remedy Meds does not include lab work or access to a registered dietitian in its standard plans, meaning patients will need to coordinate bloodwork and nutritional guidance independently.

Our editorial team finds Remedy Meds to be a capable but imperfect option. The combination of high review volume, an outcome guarantee, and rapid onboarding creates real appeal. However, the BBB complaints and gaps in ongoing clinical support prevent it from reaching the top tier. Patients who are self-directed and comfortable managing their own health data will get the most out of this platform.

At a Glance